title: Should methylene blue be the drug of choice to treat vasoplegias caused by cardiopulmonary bypass and anaphylactic shock?
authors.forename: P R
authors.initials: PR
authors.lastname: Evora
mesh_terms: D000707:Anaphylaxis / Q000188:drug therapy* / Q000209:etiology*; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D006801:Humans; D007022:Hypotension / Q000188:drug therapy* / Q000209:etiology*; D008751:Methylene Blue / Q000627:therapeutic use*; D014655:Vascular Resistance
chemical_list: D008751:Methylene Blue